Hematologic Markers of Distant Metastases and Poor Prognosis in Gynecological Cancers

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5326-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Liver Metastases From Gynecological Cancers: Time to Resection?

Surgical Science
2012English

A Nomogram for the Prediction of Prognosis in Patients With Distant Metastases of Nasopharyngeal Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Role of Gamma Knife® Radiosurgery for the Treatment of Brain Metastases From Gynecological Cancers

Cureus
2016English

NEDD9 Overexpression Predicts Poor Prognosis in Solid Cancers: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2019English

18f-FDG PET Scanning Correlates With Tissue Markers of Poor Prognosis and Predicts Mortality for Patients After Liver Resection for Colorectal Metastases

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2007English

Investigation of RIP140 and LCoR as Independent Markers for Poor Prognosis in Cervical Cancer

Oncotarget
Oncology
2017English

Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers With Poor Prognosis

Cancer Research
Cancer ResearchOncology
2008English

MARCH8 Is Associated With Poor Prognosis in Non-Small Cell Lung Cancers Patients

Oncotarget
Oncology
2017English

Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers

Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy